Salkhanova A B, Kim D K
Vopr Pitan. 2010;79(6):26-9.
The goal of the survey is the analysis of economic efficiency at 20% one-time as well as 20% and 30% even reduction of anemia prevalence. Data of Agency on statistics, Ministry of Health of Republic of Kazakhstan, and research data of Kazakh Academy of Nutrition were used for computation. The prevalence of anemia amongst men aged 15-59 years was 28,1% and amongst women aged 15-59 years--45.3%. The economic efficiency at the 20% one-time anemia prevalence reduction for 1 year accounts for 146.1 mln USD, at the 20% even reduction of anemia prevalence for 4 years--367.7 mln USD for this period or 91.9 mln USD per one year; and at 30% even reduction of anemia prevalence for 4 years--547 mln USD for this period or 136.7 mln USD per 1 year.